Long-Term Safety Uncertainty in Microdosing

Urgent first

Call 911 (US) for chest pain, trouble breathing, seizures or loss of consciousness. For thoughts of self-harm in the US, call or text 988. If someone has swallowed an unknown mushroom or plant product, call US Poison Help at 1-800-222-1222. Do not wait for symptoms to pass. This page is education, not medical advice.

The short answer

Short studies of microdosing have mostly reported few serious problems, but they last weeks, not years. How safe it is to repeat low amounts for months or longer is not known. Evidence labels: insufficient evidence (too little good research), mixed, and Proper evidence not found (we looked and found nothing usable).

What short-term studies report

• A 2026 meta-analysis found adverse event risks similar between microdosing and placebo, but it pooled only two randomized trials (109 people) for safety. [1]
• In a randomized trial of 53 adults with ADHD, repeated low-dose LSD was described as physically safe and psychologically well tolerated overall. [2]
• A review of 57 human studies found that anxiety, physical discomfort and cognitive disruption are also frequently reported. [3]
• An umbrella review described short-term tolerability as acceptable but said cardiovascular signals and long-term risks remain uncharacterized. [4]
• A small drop in cognitive control was the one consistent controlled finding in that review. [4]

The heart-valve question (5-HT2B)

Serotonin receptors are proteins on cells that respond to the chemical serotonin. One type, the 5-HT2B receptor, is discussed in relation to drug-induced heart valve damage. [5] A 2024 review in the Journal of Psychopharmacology noted that both LSD and psilocybin share structural similarities with medications that raise the risk of cardiac fibrosis and valvulopathy when taken regularly. [5] The same review said the long-term effects of microdosing on cardiac health remain unknown. [5]

What this means:

• It is a concern based on chemistry and other drugs, not a confirmed harm from microdosing in people.


• An 8-week open-label study of LSD microdosing in 19 adults with depression was the first to evaluate valvulopathy after repeated psychedelic use in humans, and it observed no clinical alterations in safety measures. It was small, short and had no placebo group. [6]


• A normal heart check after eight weeks does not tell us what happens after a year.

Who needs extra caution

• Heart conditions. NIDA says psilocybin typically raises blood pressure and heart rate, which may be dangerous for people with heart conditions. [7] That statement is about psilocybin in general, not specifically microdoses.
• Pregnancy and breastfeeding. NIDA says there is no data on the safety of taking psilocybin during pregnancy. [7] See Pregnancy and Breastfeeding.
• Psychosis, mania or bipolar-related conditions. Trials of larger sessions have excluded people with a history of psychosis or mania. [8] See Psychosis Vulnerability and Mania and Bipolar-Related Concerns. Microdosing has not been established as safe for these groups.
• Medicines. Interactions are assessed substance by substance. See Psychedelic Drug Interactions and Toxicology. Never stop or change a prescribed medicine on your own.

Quality of products

Products sold as mushroom edibles are often unregulated, with unlisted ingredients and inconsistent formulations. [9] In a laboratory analysis, even uniformly grown mushroom material varied from batch to batch. [10] A product's label therefore cannot be assumed to show what is inside. A poison-center case series of mushroom chocolates in the US had a median patient age of 17; some patients developed serious effects, and 7 of the 36 cases had irregular heart rhythms (dysrhythmias). [11]

What has not been studied well

Proper evidence not found for the following, after searching PubMed for the studies above on October 22, 2026:

• Controlled human studies of repeated microdosing lasting many months or years.
• Heart valve imaging in large groups of regular microdosers. The one small study we found is described above.

A critical review noted that future work should examine potential risks of repeated low doses, including heart rate and receptor effects, alongside cognition. [12]

Related reading

Psychedelic Adverse Effects and Contraindications covers larger-session risks. When to Seek Urgent Help lists warning signs.